- Home
- EDIT vs MNSB Comparison
EDIT vs MNSB Comparison
Compare EDIT & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- MNSB
- Stock Information
- Founded
- EDIT 2013
- MNSB 2003
- Country
- EDIT United States
- MNSB United States
- Employees
- EDIT N/A
- MNSB N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- MNSB Major Banks
- Sector
- EDIT Health Care
- MNSB Finance
- Exchange
- EDIT Nasdaq
- MNSB Nasdaq
- Market Cap
- EDIT 156.5M
- MNSB 140.7M
- IPO Year
- EDIT 2016
- MNSB N/A
- Fundamental
- Price
- EDIT $2.25
- MNSB $18.30
- Analyst Decision
- EDIT Buy
- MNSB
- Analyst Count
- EDIT 13
- MNSB 0
- Target Price
- EDIT $6.73
- MNSB N/A
- AVG Volume (30 Days)
- EDIT 2.4M
- MNSB 23.4K
- Earning Date
- EDIT 08-06-2025
- MNSB 07-28-2025
- Dividend Yield
- EDIT N/A
- MNSB 2.17%
- EPS Growth
- EDIT N/A
- MNSB N/A
- EPS
- EDIT N/A
- MNSB N/A
- Revenue
- EDIT $35,837,000.00
- MNSB $59,896,000.00
- Revenue This Year
- EDIT N/A
- MNSB $17.95
- Revenue Next Year
- EDIT N/A
- MNSB $2.52
- P/E Ratio
- EDIT N/A
- MNSB N/A
- Revenue Growth
- EDIT N/A
- MNSB N/A
- 52 Week Low
- EDIT $0.91
- MNSB $15.00
- 52 Week High
- EDIT $6.05
- MNSB $20.88
- Technical
- Relative Strength Index (RSI)
- EDIT 63.76
- MNSB 45.27
- Support Level
- EDIT $2.05
- MNSB $18.00
- Resistance Level
- EDIT $2.55
- MNSB $18.52
- Average True Range (ATR)
- EDIT 0.23
- MNSB 0.46
- MACD
- EDIT 0.03
- MNSB -0.07
- Stochastic Oscillator
- EDIT 66.29
- MNSB 24.65
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.